Ann Arbor Hematoloty-Oncology — Ann Arbor, Michigan

Ann Arbor Hematoloty-Oncology is a clinical research site located in Ann Arbor, Michigan, United States 48106.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Ann Arbor Hematoloty-Oncology has participated in 1 clinical trials.

Therapeutic areas: Metastatic Renal Cell Carcinoma.

Sponsors: NewLink Genetics Corporation.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Ann Arbor

Browse all research sites in Michigan · View every site in Ann Arbor

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ann Arbor Hematoloty-Oncology?

Ann Arbor Hematoloty-Oncology has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ann Arbor Hematoloty-Oncology conducted?

Ann Arbor Hematoloty-Oncology has 1 clinical trials on record. Their work covers Metastatic Renal Cell Carcinoma.

Is Ann Arbor Hematoloty-Oncology accredited by Crixeo Clinical Trials?

Ann Arbor Hematoloty-Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Ann Arbor Hematoloty-Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.